On January 16, 2019, Vland Biotech Group(SSE: Vland, stock code: 603739) held a listing ceremony on the Shanghai StockExchange (SSE).

Vland publicly issued 38.667 million sharesat a price of 10.19 yuan per share. The total amount of funds raised from thenew shares was 394 million yuan and the total equity after the issuance was154.667 million shares. Vland mainly engages in the production, R&D andsales of enzymes, probiotics and animal health products. In 2017, the companyachieved operating income of 799 million yuan and net profit of 92.5301 millionyuan. Vland is located in Qingdao, China and is the first company listed on SSEin Shandong Province in 2019.